http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Vaya Health and Partners Health Management Announce Merger
-
Gladia publishes the first comprehensive map of the meeting assistant market
-
Next Crypto to Hit $1? APEMARS Sends the Altcoin Season Index Into Full Launch Mode as Hedera Climbs and Uniswap Slides
-
ASUS ROG Zephyrus G14 and G16 Arrive in the US with Intel Core Ultra Series 3 and RTX 50 Series
-
WisdomTree and Clinch Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Ingalls Shipbuilding to Host On-Site Skilled Trades Hiring Event June 6
-
La Roche-Posay Announces Its Partnership Renewal with Keke Palmer As The Face Of Its Mela B3 Franchise Expansion
-
BMC South RNs and Health Professionals Cast Overwhelming Vote to Reject BMC Administration's "Last, Best & Final Offer," Call on Administration to Come Back to the Table to Negotiate a F
-
Casa Avenida Celebrates Official Groundbreaking in Downtown Delray Beach
-
PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
-
CLARITY Act Ignites Next 100x Crypto Speculation While APEMARS Gains Attention With SPX6900 And Pax Gold
-
Tú Cuentas Cine Youth Fest Wins Two Telly Awards
-
HTX Opens Trading for SFP (SafePal)
-
Green Rain Energy Holdings (GREH) Honors Fallen U.S. Service Members Ahead of Memorial Day
-
Max Power Expands and Accelerates Its Commercial Validation Program for Canada’s First Natural Hydrogen System
-
Operation HOPE’s First Quarter 2026 HOPE Insider Survey Reveals Economic Anxiety Persists, but Financial Literacy Support is Building Resilience
-
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
-
Merck receives EU committee approval recommendation for bladder cancer drug combo
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasiv
-
Gilead receives EU panel backing for Trodelvy in breast cancer treatment
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
-
ImmunityBio presents UK patient survey on bladder cancer treatment preferences
-
ImmunityBio shows cost savings for ANKTIVA plus BCG versus TAR-200
-
ImmunityBio Presents Health Economic Analysis at ISPOR 2026 Showing ANKTIVA® Plus BCG Delivers Lower Cost per Sustained Complete Response Versus TAR-200 in BCG-Unresponsive NMIBC CIS
-
ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
-
New Break Announces Receipt of DTC Eligibility in the United States
-
Bitget Turns “Crypto Is Dead” Into a Comeback with Bitcoin Pizza Day Campaign ‘Flip the Slice’
-
Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial
-
Search Engine People Launches AI Visibility Measurement Technology to Help Brands Track Performance in AI Search Results
-
ReElement Technologies and POSCO International form $200M rare earth venture
-
ReElement Technologies and POSCO International Form Joint Venture to Develop Integrated Rare Earth and Magnet Production in the United States
-
APEMARS’ Top 100X Coin Presale Near Final Call: Could its Vision, Tokenomics, and Community Growth Push Past ETH and SOL?
-
Best Crypto To Buy Today? APEMARS Gains Momentum as the CLARITY Act Reshapes Crypto Rules While Dogecoin and Comedian Hold Steady
-
New Cryptocurrency Alert: Ondo Leads RWA Buzz While SUI Traders Watch $1, AlphaPepe Builds AI Edge
-
Best Altcoin to Buy Now Debate Adds AlphaPepe as Low BTC Sell Pressure Revives Risk Appetite
-
XRP Price Prediction: CLARITY Act Support Holds XRP Near $1.45 as AlphaPepe Builds Product Proof
-
Licensing Expo Concludes with Record-Breaking Show Floor and Participation from Cultural Icons, Cementing Status as Global Epicenter for Brand Collaboration
-
Dogeball vs AlphaPepe: Next x100 Crypto Buyers Choose AI DEX Proof Over Gaming Hype
-
STL announces US Conec certification to offer MMC pre-terminated solutions for AI-Data Center deployments
-
5 Best Crypto Presales as Bitcoin Rebounds Toward $78K and Retail Hunts Earlier Entries
-
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
-
BTC News Today Signals Market Transition, Cardano Eyes Recovery, But Could APEMARS Be the Best Crypto Presale Before June 8?
-
Coupa acquires Tonkean to expand workflow automation capabilities
-
Next Shiba Inu: AlphaPepe Leads as SHIB Burn Math Still Fights the Supply Problem
-
Conduent agrees to sell public transit business to Modaxo for $164 million
-
Conduent Announces Agreement to Sell Its Public Transit Business to Modaxo for $164 Million
-
Coupa Acquires Tonkean to Accelerate Agentic Intake and Orchestration for Global Trade
-
Next Crypto To Explode: Buyers Watch AlphaPepe as Nvidia Earnings Revive Crypto Risk Appetite
-
MARY MCCORMACK TO CO-HOST THE NATIONAL MEMORIAL DAY CONCERT ON PBS, STEPPING IN FOR JOE MANTEGNA
-
Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types
